Identification and Characterization of a New Potent Inhibitor Targeting CtBP1/BARS in Melanoma Cells

0
32
Researchers identified a potent and selective inhibitor of C-terminal-binding protein 1/brefeldin A ADP-ribosylation substrate (CtBP1/BARS) active in cellular and melanoma animal models.
[Journal Of Experimental & Clinical Cancer Research]
Full Article